N9T-11476-12466
3 vaccinations
1 coded response
14 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 273 / NC
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-24
- 2020-12-25
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-02-01
- 2021-02-06
- 2021-02-19
- 2021-04-11
-
2021-12-19
Dose 3 — Pfizer-BioNTech
-
2022-01-08
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · HospitalizationFree text: Miscarriage @ 13 weeks (May 2021)MedDRA releases: 2024-11 · check-in free text available
-
2022-01-08
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2022-01-10
- 2022-01-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-12-19 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-08 | Unsuccessful |
Free text
Release 10 — 12 months, dose 2
Symptoms: Miscarriage @ 13 weeks (May 2021)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release